1
|
Gironi LC, Esposto E, Zottarelli F, Giorgione R, Farinelli P, Zavattaro E, Cammarata E, Di Cristo N, Ogliara P, Camillo L, Giordano M, Mellone S, Pasini B, Ambrosi A, Savoia P. Temporal correlation between the first melanoma and the first noncutaneous tumor in CKDN2A genotyped patients. Melanoma Res 2023; 33:425-430. [PMID: 37352544 DOI: 10.1097/cmr.0000000000000906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/25/2023]
Abstract
CDKN2A pathogenic variants are well known to be associated with cutaneous melanoma and noncutaneous tumors (NCTs). Herein, we investigated the temporal correlation between the first cutaneous melanoma and NCT both in CDKN2A mutation carriers (MUT) and in wild-type melanoma patients, a poorly explored issue to date. Two hundred forty-five cutaneous melanoma patients were genotyped for the CDKN2A gene and divided into 51 MUT and 189 wild-type; the remaining five variant carriers were excluded from the analyses. MUT developed a significantly higher number of cutaneous melanoma than wild-type, while 13.7% in both genotyped groups received a diagnosis of at least one malignant NCT, without statistically significant differences. The onset of the first cutaneous melanoma preceded that of the first malignant or benign NCT in both MUT and wild-type patients by an average of 4.5 and 3.02 years, respectively. Considering only malignant tumors, the diagnosis of melanoma preceded that of the first NCT on an average of 8 and 4.34 years, in MUT and wild-type patients respectively. We emphasize the relevance to adopt a global vision for the primary and secondary surveillance of patients affected by cutaneous melanoma, not only limited to high-risk for multiple primary skin cancers but also to NCT that may develop several years after the diagnosis of the first cutaneous melanoma.
Collapse
Affiliation(s)
| | | | | | | | | | - Elisa Zavattaro
- Department of Health Sciences, University of Eastern Piedmont, Novara
| | | | - Nunzia Di Cristo
- Department of Health Sciences, University of Eastern Piedmont, Novara
| | - Paola Ogliara
- Department of Medical Sciences, University of Turin, Turin
| | - Lara Camillo
- Department of Health Sciences, University of Eastern Piedmont, Novara
| | - Mara Giordano
- Department of Health Sciences, University of Eastern Piedmont, Novara
- SCDU of Clinical Biochemistry, Laboratory of Genetics, AOU Maggiore della Carità, Novara
| | - Simona Mellone
- SCDU of Clinical Biochemistry, Laboratory of Genetics, AOU Maggiore della Carità, Novara
| | - Barbara Pasini
- Department of Medical Sciences, University of Turin, Turin
| | - Alessandro Ambrosi
- Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy
| | - Paola Savoia
- Department of Health Sciences, University of Eastern Piedmont, Novara
| |
Collapse
|
2
|
Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA. Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011). J Am Acad Dermatol 2018; 79:238-244. [PMID: 29499295 PMCID: PMC6754624 DOI: 10.1016/j.jaad.2018.02.055] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 12/31/2017] [Accepted: 02/11/2018] [Indexed: 11/30/2022]
Abstract
BACKGROUND Survival data are mixed comparing patients with multiple primary melanomas (MPM) to those with single primary melanomas (SPM). OBJECTIVES We compared MPM versus SPM patient survival using a matching method that avoids potential biases associated with other analytic approaches. METHODS Records of 14,138 individuals obtained from the Surveillance, Epidemiology, and End Results registry of all melanomas diagnosed or treated in Utah between 1973 and 2011 were reviewed. A single matched control patient was selected randomly from the SPM cohort for each MPM patient, with the restriction that they survived at least as long as the interval between the first and second diagnoses for the matched MPM patient. RESULTS Survival curves (n = 887 for both MPM and SPM groups) without covariates showed a significant survival disadvantage for MPM patients (chi-squared 39.29, P < .001). However, a multivariate Cox proportional hazards model showed no significant survival difference (hazard ratio 1.07, P = .55). Restricting the multivariate analysis to invasive melanomas also showed no significant survival difference (hazard ratio 0.99, P = .96). LIMITATIONS Breslow depth, ulceration status, and specific cause of death were not available for all patients. CONCLUSIONS Patients with MPM had similar survival times as patients with SPM.
Collapse
Affiliation(s)
- Douglas Grossman
- Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah; Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah.
| | - James M Farnham
- Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - John Hyngstrom
- Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Marki E Klapperich
- University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin
| | - Aaron M Secrest
- Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Sarah Empey
- Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Glen M Bowen
- Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - David Wada
- Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Robert H I Andtbacka
- Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Kenneth Grossmann
- Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Tawnya L Bowles
- Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah
| | - Lisa A Cannon-Albright
- Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah
| |
Collapse
|
3
|
Lee HJ, Jin H, You HS, Shim WH, Kim JM, Kim GW, Mun JH, Kim HS, Ko HC, Kim BS, Kim MB. Various Dermatoses What the Patients with Cutaneous Melanoma Had Anxiety for the Recurrence during Postoperative Surveillance. Ann Dermatol 2017; 29:433-437. [PMID: 28761291 PMCID: PMC5500708 DOI: 10.5021/ad.2017.29.4.433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2016] [Revised: 09/21/2016] [Accepted: 09/29/2016] [Indexed: 11/08/2022] Open
Abstract
BACKGROUND The incidence and mortality rates associated with cutaneous melanoma (CM) have steadily increased over the last 20 years. Even with successful treatment, melanoma patients usually experience substantial anxiety regarding the development of terrible recurrence. To date, few studies have investigated various dermatoses what the patients with CM had anxiety for the recurrence during postoperative surveillance (Dw). OBJECTIVE To describe various Dw and to evaluate the risk of subsequent malignant skin disease in patients with CM. METHODS We performed a prospective study between August 2002 and August 2015. RESULTS Fifty-six patients presented with a total of 68 Dw. Among them, melanocytic nevus was the most common (n=27), followed by seborrheic keratosis (n=9) and CM recurrence (n=7). Approximately 5.6% of the lesions were diagnosed as malignant skin diseases. This was a single-center study, so the prevalence of malignant skin diseases following primary melanoma may not represent that of all patients with CM. CONCLUSION The results of this study can be referred by dermatologists dealing with melanoma especially when CM patients have too excessive or unrealistic anxiety for melanoma recurrence during postoperative surveillance of CM. However, the importance of postoperative surveillance must still be emphasized because of real risk of melanoma recurrence and other malignant skin.
Collapse
Affiliation(s)
- Hyun-Joo Lee
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Hyunju Jin
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Hyang-Suk You
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Woo-Haing Shim
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Jeong-Min Kim
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Gun-Wook Kim
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Je-Ho Mun
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
| | - Hoon-Soo Kim
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea
| | - Hyun-Chang Ko
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea.,Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea
| | - Byung-Soo Kim
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
| | - Moon-Bum Kim
- Department of Dermatology, Pusan National University School of Medicine, Busan, Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
| |
Collapse
|
4
|
Sula B, Uçmak F, Kaplan MA, Urakçi Z, Arica M, Isikdogan A. Epidemiological and clinical characteristics of malignant melanoma in Southeast Anatolia in Turkey. Pan Afr Med J 2016; 24:22. [PMID: 27583086 PMCID: PMC4992363 DOI: 10.11604/pamj.2016.24.22.9254] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Accepted: 04/27/2016] [Indexed: 01/07/2023] Open
Abstract
INTRODUCTION The present study aimed to establish the epidemiological and clinical characteristics of patients who were histopathologically diagnosed with malignant melanoma (MM). METHODS The present study retrospectively analyzed the data of 78 patients who were histopathologically diagnosed with MM in Dicle University Medical Faculty, Dermatology and Medical Oncology departments between 2005 and 2014. RESULTS The study included 78 patients in total with 44 (56.4%) male and 34 (43.6%) female. Median age of the patients was 62.50 years (range: 27 - 84 years). Of the patients, 78.2% (n = 61) had cutaneous melanoma, 8.9% had solid organ melanoma, and 2.5% had ocular and mucosal melanoma. The most common tumor localization among the patients was the lower extremities with 29.4% (n = 23). The most common histopathological type was nodular malignant melanoma with 35.8% (n = 28). Based on TNM, Clark and Breslow classifications, 26.9% (n = 21) of the patients were stage 4, 26.9% (n = 21) were Clark stage 4, and 37.1% (n = 29) were Breslow stage 4. Median overall survival in all patients was 14.9 months (95% CI 10.9 - 18.8 months). In the multivariate Cox analysis, only stage statistically significantly affecting survival [odds ratio (OR): 0.54; (95% CI 0.16-1.82, p = 0.02)]. CONCLUSION Malignant melanoma data are also important for the optimal utilization of effective methods and healthcare resources to prevent the disease. In order to minimize MM mortality and morbidity, not only the society but also physicians from primary and secondary care hospitals should become familiar with melanoma.
Collapse
Affiliation(s)
- Bilal Sula
- Department of Dermatology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| | - Feyzullah Uçmak
- Department of Gastroenterology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| | - Mehmet Ali Kaplan
- Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| | - Zuhat Urakçi
- Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| | - Mustafa Arica
- Department of Dermatology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| | - Abdurrahman Isikdogan
- Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
| |
Collapse
|
5
|
Brandão FV, Pereira AFJR, Gontijo B, Bittencourt FV. Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years. An Bras Dermatol 2014; 88:344-53. [PMID: 23793193 PMCID: PMC3754364 DOI: 10.1590/abd1806-4841.20131855] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2012] [Accepted: 08/07/2012] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND The incidence of melanoma has been steadily rising in past decades. Although it
accounts for only 3% of all skin cancers, it is responsible for 75% of deaths.
OBJECTIVE to describe the epidemiological aspects of melanoma in a university hospital
setting over a period of 20 years. METHODS A total of 166 patients were analyzed between January 1990 and January 2010 for
clinical and histological variables and correlations between them. A 5% level of
significance was adopted. RESULTS The majority of patients were Caucasians (74%), females (61%), with a mean age at
diagnosis of 55. The predominant histological type was lentigo maligna/lentigo
maligna melanoma (35.7%) and the head and neck was the most affected site (30.7%).
Among non-Caucasians, the acral region was the most affected. Most tumors were in
situ (41.1%). Growth of the lesion was the most frequent complaint (58.1%) and
bleeding was most frequently associated with melanomas with a depth > 4mm.
There were seven deaths (4.2%), with a high risk among men, non-Caucasians and
those under 20 years of age, with a Breslow's depth > 2mm, with lentiginous
acral melanoma and with a history of growth and bleeding. CONCLUSIONS Our sample differs from most of the studies in the predominant location (head and
neck), histological type (lentigo maligna/ lentigo maligna melanoma) and a major
risk of death under the age of 20, which could be with a reflex of regional
variation. Broader studies are necessary for validation of the results.
Collapse
Affiliation(s)
- Flavia Vieira Brandão
- Brasilia University (UnB), Hospital Universitário de Brasilia, Brasilia, DF, Brazil.
| | | | | | | |
Collapse
|
6
|
Manganoni MA, Pavoni L, Farisoglio C, Sereni E, Calzavara-Pinton P. Risk of oral cavity malignancies in patients with cutaneous melanoma. J Oral Pathol Med 2011; 41:648. [PMID: 22106926 DOI: 10.1111/j.1600-0714.2011.01118.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|